Abstract
Background
Methods
Results
Conclusions
Keywords
Abbreviations:
SBI (Silent brain infarcts), WMH (White matter hyperintensities), AF (atrial fibrillation)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesReferences
- Atrial fibrillation as an independent risk factor for stroke: the framingham study.Stroke. 1991; 22: 983-988https://doi.org/10.1161/01.STR.22.8.983
- A population-based study of the long-term risks associated with atrial fibrillation: 20-Year follow-up of the renfrew/paisley study.Am J Med. 2002; 113: 359-364https://doi.org/10.1016/S0002-9343(02)01236-6
- Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study.Stroke. 2005; 36: 1115-1119https://doi.org/10.1161/01.STR.0000166053.83476.4a
- Andreas Terént, Bo Norrving KA. High prevalence of atrial fibrillation among patients with ischemic stroke.Stroke. 2014; 45: 2599-2605https://doi.org/10.1161/STROKEAHA.114.006070
- Silent brain infarcts: a systematic review.Lancet Neurol. 2007; 6: 611-619https://doi.org/10.1016/S1474-4422(07)70170-9
- Association between Atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis.Ann Intern Med. 2014; 161: 650-658https://doi.org/10.7326/M14-0538
- Emerging spectra of silent brain infarction.Stroke. 2014; 45: 3461-3471https://doi.org/10.1161/STROKEAHA.114.005919
- Silent brain infarction and risk of future stroke: a systematic review and meta-analysis.Stroke. 2016; 47: 719-725https://doi.org/10.1161/STROKEAHA.115.011889
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation.Chest. 2010; 137: 263-272https://doi.org/10.1378/chest.09-1584
- Prevalence and risk factors of silent brain infarcts in patients with AF detected by 3T-MRI.J Neurol. 2020; 267: 2675-2682https://doi.org/10.1007/s00415-020-09887-0
- Cognitive impairment associated with atrial fibrillation: a meta- analysis.Ann Intern Med. 2013; 158 (Cognitive): 338-346https://doi.org/10.7326/0003-4819-158-5-201303050-00007
- Atrial fibrillation and dementia: a report from the AF-SCREEN international collaboration.Circulation. 2022; 145: 392-409https://doi.org/10.1161/CIRCULATIONAHA.121.055018
- Atrial fibrillation and cognitive function: JACC review topic of the week.J Am Coll Cardiol. 2019; 73: 612-619https://doi.org/10.1016/j.jacc.2018.10.077
- Atrial Fibrillation and cognitive decline: phenomenon or epiphenomenon?.Cardiol Clin. 2016; 34: 279-285https://doi.org/10.1016/j.ccl.2015.12.011
- Atrial fibrillation and the risk of cerebral white matter lesions.Neurology. 2000; 54: 1795-1800https://doi.org/10.1212/wnl.54.9.1795
- Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation.J Stroke Cerebrovasc Dis. 2012; 21: 310-317https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.09.004
- Cerebral blood flow in small vessel disease: a systematic review and meta-analysis.J Cereb Blood Flow Metab. 2016; 36: 1653-1667https://doi.org/10.1177/0271678×16662891
- Biomarkers in atrial fibrillation: pathogenesis and clinical implications.Card Electrophysiol Clin. 2021; 13: 221-233https://doi.org/10.1016/j.ccep.2020.10.006
Palà E., Bustamante A., Pagola J., et al. Blood-based biomarkers to search for atrial fibrillation in high-risk asymptomatic individuals and cryptogenic stroke patients. 2022;9(July):1-11. doi:10.3389/fcvm.2022.908053
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.Lancet Neurol. 2013; 12: 822-838https://doi.org/10.1016/S1474-4422(13)70124-8
Smith E.E., Saposnik G., Biessels G.J., et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American heart association/American stroke association. Vol 48.; 2017. doi:10.1161/STR.0000000000000116
- MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.Am J Neuroradiol. 1987; 8: 421-426
- The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment.J Am Geriatr Soc. 2005; 53: 695-699https://doi.org/10.1111/j.1532-5415.2005.53221.x
- Validation of the spanish-language version of the montreal cognitive assessment test in adults older than 60 years.Neurologia. 2019; 34: 376-385https://doi.org/10.1016/j.nrl.2017.01.013
- Montreal cognitive assessment test: normalization and standardization for Spanish population.Rev Neurol. 2016; 63: 488-496https://doi.org/10.33588/rn.6311.2016241
- Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.BMC Cardiovasc Disord. 2021; 21: 1-11https://doi.org/10.1186/s12872-021-02358-y
- The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.Eur Heart J. 2016; 37: 1582-1590https://doi.org/10.1093/eurheartj/ehw054
- Biomarkers, clinical variables, and the CHA2DS2-VASc score to detect silent brain infarcts in atrial fibrillation patients.J Stroke. 2021; 23: 449-452https://doi.org/10.5853/jos.2021.02068
- Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American heart association/American stroke association.Stroke. 2017; 48: e44-e71https://doi.org/10.1161/STR.0000000000000116
- Proteomics and risk of atrial fibrillation in older adults (from the atherosclerosis risk in communities [ARIC] study).Am J Cardiol. 2021; 161: 42-50https://doi.org/10.1016/j.amjcard.2021.08.064
- Proteomics Profiling and Risk of New-Onset Atrial Fibrillation: Framingham Heart Study.J Am Heart Assoc. 2019; 8https://doi.org/10.1161/JAHA.118.010976
- Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?.Chest. 2007; 132: 1913-1919https://doi.org/10.1378/chest.07-1565
- Angiogenic factors in a trial fibrillation: a possible role in thrombogenesis?.Ann Med. 2005; 37: 365-372https://doi.org/10.1080/07853890510037392
- Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: a validation study.PLoS Med. 2021; 18: 1-17https://doi.org/10.1371/JOURNAL.PMED.1003405
- Fibroblast growth factor-23 and incident atrial fibrillation: the multi-ethnic study otherosclerosis (MESA) and the cardiovascular health study (CHS).Circulation. 2014; 130: 298-307https://doi.org/10.1161/CIRCULATIONAHA.113.005499.Fibroblast
- Fibroblast growth factor 23 is associated with subclinical cerebrovascular damage: the northern manhattan study (NOMAS).Stroke. 2016; 47: 923-928https://doi.org/10.1161/STROKEAHA.115.012379.Fibroblast
- Heart specific expression of mouse BMP-10 a novel member of the TGF-β superfamily.Mech Dev. 1999; 80: 181-184https://doi.org/10.1016/S0925-4773(98)00221-4
- Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation.JCI Insight. 2020; 5: 1-16https://doi.org/10.1172/jci.insight.139179
- 13230: bone morphogenetic protein 10 - a novel biomarker of ischemic stroke in patients with atrial fibrillation.Circulation. 2021; : 144https://doi.org/10.1161/circ.144.suppl_1.13230
- The cell-specific upregulation of bone morphogenetic protein-10 (BMP-10) in a model of rat cortical brain injury.J Mol Histol. 2012; 43: 543-552https://doi.org/10.1007/s10735-012-9431-1
- Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation.Sci Rep. 2022; 12: 1-11https://doi.org/10.1038/s41598-022-05769-9
- The multiple causes of stroke in atrial fibrillation: thinking broadly.Can J Cardiol. 2018; 34: 1503-1511https://doi.org/10.1016/j.cjca.2018.08.036
- Cerebral small vessel disease associated with atrial fibrillation among older adults: a population-based study.Stroke. 2021; (August): 2685-2689https://doi.org/10.1161/STROKEAHA.120.031573
- Growth differentiation factor 15 and nt-probnp as blood-based markers of vascular brain injury and dementia.J Am Heart Assoc. 2020; 9https://doi.org/10.1161/JAHA.119.014659
- Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis.Stroke. 2013; 44: 1803-1808https://doi.org/10.1161/STROKEAHA.113.001128.Cardiovascular
- N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease.Neurology. 2016; 87: 2533-2539https://doi.org/10.1212/WNL.0000000000003423
- Age-related cerebral white matter disease (Leukoaraiosis): a review.Postgrad Med J. 2012; 88: 79-87https://doi.org/10.1136/postgradmedj-2011-130307
- Covert brain infarction: towards precision medicine in research, diagnosis, and therapy for a silent pandemic.Stroke. 2020; 51: 2597-2606https://doi.org/10.1161/STROKEAHA.120.030686
Article info
Publication history
Footnotes
Grant support: A Junta de Andalucía grant (PIN-0144-2016) supported partially the study. The Fundación Cajasol contributed to the study. Neurovascular Research Groups at Seville and Barcelona are part of the Spanish Neurovascular Disease Research Network (RICORS-ICTUS, RD21/0006/0007). Some authors are partially funded by European Union's Horizon 2020 research and innovation program under grant agreements 847770 and 754517.
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106833